NuCana

NCNA · NASDAQ

$0.9853+$0.0253 (+2.64%)TodayMarket closed ·
Prev close $0.96

Latest news

  • Press releaseGlobe Newswire

    NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in Europe

  • Press releaseGlobe Newswire

    NuCana Reports Second Quarter 2026 Financial Results and Provides Business Update

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    NuCana Appoints Ian Webster as Chief Financial Officer

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseGlobe Newswire

    NuCana Reports First Quarter 2026 Financial Results and Provides Business Update

  • NewsAvi Kapoor

    AST SpaceMobile, SBC Medical Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Press releaseGlobe Newswire

    NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update

  • NewsAvi Kapoor

    Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • Press releaseGlobe Newswire

    NuCana Appoints Theresa Bruce as Chief Operating Officer

  • Press releaseGlobe Newswire

    NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update

  • Press releaseGlobe Newswire

    NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Press releaseGlobe Newswire

    NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025

  • NewsAvi Kapoor

    Penguin Solutions Posts Q4 Earnings, Joins Esperion Therapeutics, Joby Aviation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    IBEX, Tesla, IonQ, Warner Bros. Discovery And Other Big Stocks Moving Higher On Friday

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • NewsAvi Kapoor

    US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • NewsAvi Kapoor

    Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    US Stocks Higher; Lyft Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Dow Jumps Over 200 Points; US Initial Jobless Claims Fall

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • NewsAvi Kapoor

    Crude Oil Rises Sharply; US Trade Deficit Widens In March

  • NewsAvi Kapoor

    Dow Falls Over 250 Points; Marriott Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • Press releaseBusiness Wire

    Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.